QUCY Quantum Cyber

NEUTRAL Impact: 3/10 PRESS-RELEASE
Horizon weeks Filed May 14, 2026 Processed 27d 5h ago Wire GlobeNewswire
Press release: announcement
Latest settled — T+5d
QUCY ▲ +18.67% at T+5d
NEUTRAL call ✓ call won +18.67% · α vs SPY +19.38% · entry $3.00 → $3.56
Next anchor: T+20d tomorrow
Currently $1.95 · -35.00% from $3.00 entry
Entry anchored
May 14, 08:00 AM ET
via Databento tick
T+1d
+15.33%
call +15.33% · α +16.56%
$3.46
settled 26d ago
T+5d
+18.67%
call +18.67% · α +19.38%
$3.56
settled 20d ago
T+20d
call — · α —
tomorrow
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Quantum Cyber appointed Peter M. O'Rourke Sr., former Acting Secretary of the VA and military veteran, as an independent board member. The appointment adds government procurement expertise and defense-sector credibility but provides no financial data, revenue, or concrete business catalysts — it is a governance enhancement for a pre-revenue defense-tech company.

Actionable Insight

The appointment adds government procurement credibility but provides no near-term revenue catalyst. Monitor for subsequent contract announcements or partnership developments leveraging O'Rourke's network. The stock's micro-cap status and pre-revenue profile mean sentiment-driven moves are possible, but fundamentals unchanged.

Key Facts

  • Peter M. O'Rourke Sr. appointed as independent board member, effective immediately.
  • O'Rourke served as Acting Secretary of the VA under the Trump administration, overseeing a $180B budget and 380,000 employees.
  • He brings Nasdaq board experience as Chairman of Northview Acquisition Corp. and Lead Independent Director of ProFusa.
  • Appointment follows Quantum Cyber's IP License and Commercial Supply Agreement with BP United Inc. for autonomous drone technology.
  • No financial figures, revenue, earnings, or guidance were disclosed in the press release.

Financial Impact

No financial impact disclosed; appointment is a governance move with no direct revenue or cost implications.

Risk Factors

  • No revenue or earnings disclosed — company remains pre-revenue with execution risk on technology integration.
  • Forward-looking statements about government procurement and defense funding are aspirational, not contractual.
  • Micro-cap stock ($17M market cap) with low liquidity and high volatility risk.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3294898
19 reports for QUCY
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+5▲ +16.85%Apr 28, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
Type Now
Jun 5, 2026
4d ago
8-K
NEUTRAL ★ 3/10
$2.19 awaiting T+1awaiting T+1$1.95 (−10.75%)
Jun 4, 2026
6d ago
S-3
BEARISH ★ 7/10
$2.33 $2.20▲ +5.58%▲ +2.98%$1.95 (+16.30%)
Jun 3, 2026
7d ago
8-K
MIXED ★ 5/10
$2.46 $2.33▼ −5.28%▼ −5.68%$1.95 (−20.73%)
Jun 3, 2026
7d ago
Press Release
NEUTRAL ★ 3/10
$2.46 $2.33▼ −5.28%▼ −5.68%$1.95 (−20.73%)
Jun 2, 2026
8d ago
Press Release
NEUTRAL ★ 4/10
$2.45 $2.46▲ +0.41%▲ +1.10%$1.95 (−20.40%)
May 27, 2026
14d ago
Press Release
NEUTRAL ★ 4/10
$2.93 $2.98▲ +1.71%▲ +1.15%$1.95 (−33.44%)
May 26, 2026
15d ago
Press Release
BULLISH ★ 7/10
$3.47 $2.93▼ −15.56%▼ −15.58%$1.95 (−43.80%)
May 22, 2026
19d ago
144
NEUTRAL ★ 3/10
$3.33 $3.47▲ +4.20%▲ +3.62%$1.95 (−41.44%)
May 20, 2026
21d ago
Press Release
NEUTRAL ★ 4/10
$3.29 $3.56▲ +8.21%▲ +8.01%$1.95 (−40.73%)
May 18, 2026
22d ago
144
BEARISH ★ 5/10
$2.52 $3.29▼ −30.56%▼ −29.52%$1.95 (+22.62%)
Showing 10 of 19

US Market Status

Market Open — Closes in 2h 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access